Zenas BioPharma, Inc. (ZBIO)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Leon Oliver Moulder Jr., M.B.A.
|
Founder, CEO & Chairman | 891.8k | -- | 1957 |
|
Mr. Joseph L. Farmer
|
COO, President, Principal Financial Officer & Principal Accounting Officer | 877.5k | -- | 1972 |
|
Dr. Lisa von Moltke M.D.
|
Head of Research & Development and Chief Medical Officer | 759.57k | -- | 1959 |
|
Dr. Heinrich Schlieker Ph.D.
|
Chief Technical Officer | -- | -- | -- |
|
Dr. Haley Laken Ph.D.
|
Chief Scientific Officer | -- | -- | -- |
|
Ms. Caroline Chevalier
|
Chief Administrative Officer | -- | -- | -- |
|
Ms. Abigail Lee Gray
|
Director of Investor Relations | -- | -- | -- |
|
Mr. Jerald Korn J.D.
|
Chief Legal and Strategy Officer | -- | -- | 1979 |
Zenas BioPharma, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 167
Description
Zenas BioPharma, Inc., a clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc?RIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a CTLA-4-Ig fusion protein designed to have an extended half-life versus; and ZB001, an anti-IGF-1R monoclonal antibody. The company was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is headquartered in Waltham, Massachusetts.
Corporate Governance
Upcoming Events
November 12, 2026 at 1:30 PM UTC
Zenas BioPharma, Inc. Earnings Date
